described.4 Reports of bioactive carba analogues of eudis-
tomines5 prompted us to test the reactivity of bicyclic indole
derivatives 2 or 4 toward the synthesis of new polycyclic
scaffolds.
reactions involving reactive iminium species.6 Side chain
O-protection was first performed to avoid any competitive
morpholine formation (Scheme 2).7,8 Subsequent imine
We first focused on the preparation of 2-substituted
3-aminoazepane 3 in the N-methyl indole series. The imino
bicyclic compound 6 can be prepared in multigram quantities
using Et2O-TMEDA as the solvent system. High and
reproducible yields were obtained following an optimized
sonication procedure. Standard reductive conditions were
then applied to achieve diastereoselective access to the
3-aminoazepane core.
Scheme 2. Chemoselective Activation of Bicyclic Aminal 8
Although ring enlargement in the phenyl or furyl series
proceeded at room temperature,3b harsher reaction conditions
(an excess of reagent in refluxing isopropyl ether) were
needed to achieve ring enlargement in the indole series
(Scheme 1). Thus, unprotected 2-substituted 3-aminoazepane
Scheme 1. Reductive Ring Enlargement in the Indole Series
reduction was conducted using LAH under mild conditions,
leading to compound 8 in a diastereomerically pure form.9
Methylmagnesium bromide was used as the external
nucleophilic reagent for the alkylative ring-enlargement
process. Best results were obtained using a slight excess (3.5
equiv) of Grignard reagent in refluxing Et2O, leading to
compound 9 in 51% yield as a single diastereomer. Its 2,7-
trans relative configuration could be assigned by comparison
to previous spectroscopic data in the phenyl series.3b
Compound 10, resulting from the intramolecular nucleo-
philic attack of indole C3, was never detected in the ring
enlargement reaction mixture, indicating a fully chemo-
selective seven-membered iminium ion formation. However,
this bridged heterocycle was isolated when aminal 8 was
purified by chromatography on silica gel and could also be
obtained in modest but reproducible yield by adding SiO2
directly to a solution of aminal 8.
As a nonprotected indole moiety could be of interest in
the search for bioactive products, we applied our initial
alkylation step using N-phenylsulfonylindole (Scheme 3).
Lithiated sulfonylindole proved to be unreactive with
compound 1 in Et2O but, in THF, led to a new bridged
tetracycle 11 characterized by an exo imine function (carbon
peak at 165.3 ppm) and a deshielded H-6 proton signal (δ
) 5.52 ppm). Interestingly, a desulfonylation of the indole
moiety occurred during this synthetic transformation.10 The
same compound could be obtained using the carboxylated
indole as a nucleophilic species under the standard conditions
reported by Katritzky and co-workers.11 The formation of
the tetracycle 11 can be easily explained by an intramolecular
attack of the transient N-lithiated indole species on the
derivative 7 was obtained in 74% overall yield from 1 after
hydrogenolysis of the chiral appendage. The trans relative
configuration was assigned by comparison with previously
reported structures (J2,3 ) 9.6 Hz).3
Intra- or intermolecular nucleophilic attack was then
evaluated on the bicyclic aminal system 8. The indole nucleus
was expected to compete with an external nucleophile in
(3) (a) Cutri, S.; Bonin, M.; Micouin, L.; Froelich, O.; Quirion, J.-C.;
Husson, H.-P. Tetrahedron Lett. 2000, 41, 1179. (b) Cutri, S.; Bonin, M.;
Micouin, L.; Chiaroni, A.; Husson, H.-P. J. Org. Chem. 2003, 68, 2645.
(4) (a) Ennis, M. D.; Hoffman, R. L.; Ghazal, N. B.; Olson, R. M.;
Knauer, C. S.; Chio, C. L.; Hyslop, D. K.; Campbell, J. E.; Fitzgerald, L.
W.; Nichols, N. F.; Svensson, K. A.; McCall, R. B.; Haber, C. L.; Kagey,
M. L.; Dinh, D. M. Bioorg. Med. Chem. Lett. 2003, 2369. (b) Fre´de´rich,
M.; Jacquier, M.-J.; The´penier, P.; De Mol, P.; Philippe, G.; Delaude, C.;
Angenot, L.; Ze`ches-Hanrot, M. J. Nat. Prod. 2002, 65, 1382. (c) Bennasar,
M.-L.; Jimenez, J.-M.; Vidal, B.; Sufi, A.; Bosch, J. J. Org. Chem. 1999,
64, 9605.
(5) Isolation eudistomins: (a) Rinehart, K. L., Jr.; Kobayashi, J.; Harbour,
G. C.; Hughes, R. G., Jr.; Mizsak, S. A.; Scahill, T. A. J. Am. Chem. Soc.
1984, 106, 1524. Biological activities: (b) Van Maerseveen, J. H.;
Hermkens, P. H. H.; De Clercq, E.; Balzarini, J.; Scheeren, H. W.; Kruse,
C. G. J. Med. Chem. 1992, 35, 3223. Synthesis and analogues: (c) Van
Maerseveen, J. H.; Scheeren, H. W.; De Clercq, E.; Balzarini, J.; Kruse, C.
G. Bioorg. Med. Chem. 1997, 5, 955. (d) Liu, J.-J.; Hino, T.; Tsuruoka, A.;
Nakagawa, M. J. Chem. Soc., Perkin Trans. 1 2000, 3487. (e) Yamashita,
T.; Tokuyama, H.; Fukuyama, T. Synlett 2003, 5, 738. (f) Kurihara, T.;
Sakamoto, Y.; Kimura, T.; Ohishi, H.; Harusawa, S.; Yoneda, R.; Suzutani,
T.; Azuma, M. Chem. Pharm. Bull. 1996, 44, 900.
(6) For a recent review on the synthesis of heterocycles based on iminium
ion cyclizations, see: Royer, J.; Bonin, M.; Micouin, L. Chem. ReV. 2004,
104, 2311.
(7) Froelich, O.; Desos, P.; Bonin, M.; Quirion, J.-C.; Husson, H.-P. J.
Org. Chem. 1996, 61, 6700.
(8) Compound 8 could be characterized by NMR, but all attempts of
chromatographic purifications led to its rearrangement or degradation.
(9) Absolute configuration of the newly created center was determined
unambiguously by chemical correlation with the corresponding O-silylated
piperidine.3b
(10) Sundberg, R. J.; Broome, R.; PowersWalters, C.; Schnur, D. J.
Heterocycl. Chem. 1981, 18, 807.
(11) Katritzky, A. R.; Akutagawa, K. Tetrahedron Lett. 1985, 26, 5935.
1912
Org. Lett., Vol. 7, No. 10, 2005